Mustang Bio (MBIO) Market Capitalization (2017 - 2026)

Mustang Bio (MBIO) has reported Market Capitalization for 10 consecutive years, with $4.7 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Market Capitalization rose 40.43% year-over-year to $4.7 million in Q2 2026; TTM through Jun 2026 was $4.7 million, a 40.43% increase from a year earlier, with the FY2025 full-year figure at $4.8 million, down 10.86% from the prior year.
• Market Capitalization was $4.7 million for Q2 2026 at Mustang Bio, down from $4.9 million in the prior quarter.
• Over five years, Market Capitalization peaked at $5.1 billion in Q1 2022 and troughed at $3.4 million in Q2 2025.
• A 5-year average of $1.1 billion and a median of $521.6 million in 2024 frame the typical range for Market Capitalization.
• Across the five-year window, Market Capitalization tumbled 99.39% in 2025 and surged 40.43% in 2026, its largest moves.
• Over 5 years, Market Capitalization stood at $2.1 billion in 2022, then tumbled by 73.12% to $565.3 million in 2023, then slumped by 99.05% to $5.4 million in 2024, then slipped by 10.86% to $4.8 million in 2025, then slipped by 2.03% to $4.7 million in 2026.
• The last three Market Capitalization figures came in at $4.7 million (Q2 2026), $4.9 million (Q1 2026), and $4.8 million (Q4 2025), per Business Quant data.